Bone Biologics (BBLG)

• Market cap: $2.23M
• 1 day: 6.9%
• 5 days: 9.73%
• 1 month: 4.2%
• 3 months: -19.48%
• 6 months: -51.37%
• Year to date: -19.48%
• 1 year: -75.49%
• 5 years: -99.98%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Employees: 2